ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 637729 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 637729; 2) Community: the network communities that were significantly associated with the response to NSC 637729; 3) Molecule: the relationships between components within communities and NSC 637729; 4) MDR: the compounds that were significantly associated with the NSC 637729.

NSC Compound Enrichment Correlation
NSC 730944 3-bromo-4-(2-(4-methoxyphenyl)ethynyl)furan-2(5H)-one 0.0385613993886001 0.03561513
NSC 731928 haterumalide NA methyl esters 0.0385613993886001 -0.03693766
NSC 747825 3-(4-fluorophenyl)-8,9-dimethyl-2-oxo-2,5-dihydropyrano[3,2-c]chromen-5-yl acetate 0.0385613993886001 0.29367955
NSC 748906 Hookerianamide K 0.0385613993886001 0.29136078
NSC 7521 [(6-Deoxy-.alpha.-L-mannopyranosyl)oxy]-14-hydroxybufa-4,20,22-trienolide 0.0385613993886001 -0.11198749
NSC 756420 SB-223133 0.0385613993886001 -0.19067382
NSC 758671 ANCITABINE HYDROCHLORIDE 0.0385613993886001 -0.033468774
NSC 88916 10,13-dimethyl-17-(2-methyl-1,3-thiazol-4-yl)-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one 0.0385613993886001 0.075027145
NSC 116693 Null 0.0414190425892865 0.30923479
NSC 116878 Cardiac glycoside 0.0414190425892865 -0.064661269
Total:61  Current:42    [First] [Prev] [Next] [Last]